Form 4 for TECH Bio-Techne
Accepted 2022-06-09 00:00:00 ET · period of report 2022-06-07 · accession 0001415889-22-006392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-09 | 2022-06-07+ | TECH | HIGGINS JOHN L | Dir | S - Sale+OE | $364.98 | -1,600 | 4,606 | -26% | -$584.0K |
| DM | 2022-06-09 | 2022-06-07+ | TECH | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +1,600 | 5,206 | +44% | +$107.0K |
| DM | 2022-06-09 | 2022-06-07+ | TECH | HIGGINS JOHN L | Dir | M - OptEx | $0.00 | -1,600 | 3,400 | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | S | D | 600 | $366.09 | 4,606 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 366.0000 to 366.1900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2022-06-07 | S | D | 1,000 | $364.31 | 4,606 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 364.0000 to 364.6400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-06-07 | M | A | 1,000 | $66.90 | 5,606 | D | — | — | |
| 4 | Common | Common Stock | 2022-06-08 | M | A | 600 | $66.90 | 5,206 | D | — | — | |
| 5 | Derivative | Stock Options (Right to Buy) | 2022-06-07 | M | D | 1,000 | $0.00 | 4,000 | D | $66.90 · 2012-10-25 to 2022-10-24 | 5,000 Common Stock | |
| 6 | Derivative | Stock Options (Right to Buy) | 2022-06-08 | M | D | 600 | $0.00 | 3,400 | D | $66.90 · 2012-10-25 to 2022-10-24 | 4,000 Common Stock |